Canevelli, Marco http://orcid.org/0000-0001-7333-6478
,
Arisi, Ivan
Bacigalupo, Ilaria
Arighi, Andrea
Galimberti, Daniela
Vanacore, Nicola
D’Onofrio, Mara
Cesari, Matteo
Bruno, Giuseppe
Funding for this research was provided by:
Regione Lazio (POR (Operative Program Lazio Region, Italy) FESR (European Program Regional Development) 2014 - 2020. Public Notice "LIFE 2020", MODIAG Project.)
Article History
Received: 6 August 2020
Accepted: 23 October 2020
First Online: 19 November 2020
Compliance with ethical standards
:
: The authors have no conflicts of interest to disclose for the present study. Marco Canevelli is supported by a research grant of the Italian Ministry of Health (GR-2016-02364975) for the project “Dementia in immigrants and ethnic minorities living in Italy: clinical-epidemiological aspects and public health perspectives” (ImmiDem). Matteo Cesari has received honoraria for presentations at scientific meetings and/or research funding from Nestlé and Pfizer. He is involved in the coordination of an Innovative Medicines Initiative–funded project (including partners from the European Federation Pharmaceutical Industries and Associates [Sanofi, Novartis, Servier, GSK, Lilly]).
: As per ADNI protocols, all procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards. More details can be found at adni.loni.usc.edu. The study was approved by the institutional review boards of all the participating institutions, and informed written consent was obtained from all participants at each site. This article does not contain any studies with human participants performed by any of the authors.
: Consent for publication has been granted by ADNI administrators.